A latent allocation model for the analysis of microbial composition and disease
暂无分享,去创建一个
Teppei Shimamura | Ko Abe | Kinji Ohno | Masaaki Hirayama | T. Shimamura | K. Ohno | M. Hirayama | Ko Abe
[1] M. Pop,et al. Robust methods for differential abundance analysis in marker gene surveys , 2013, Nature Methods.
[2] Jesse R. Zaneveld,et al. Normalization and microbial differential abundance strategies depend upon data characteristics , 2017, Microbiome.
[3] James T. Morton,et al. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome , 2017, Movement disorders : official journal of the Movement Disorder Society.
[4] Hongzhe Li,et al. A two-part mixed-effects model for analyzing longitudinal microbiome compositional data , 2016, Bioinform..
[5] E. Pekkonen,et al. Gut microbiota are related to Parkinson's disease and clinical phenotype , 2015, Movement disorders : official journal of the Movement Disorder Society.
[6] H. Qin,et al. The role of gut microbiota in the pathogenesis of colorectal cancer , 2013, Tumor Biology.
[7] Charles E. Robertson,et al. Application of Two-Part Statistics for Comparison of Sequence Variant Counts , 2011, PloS one.
[8] A. Heintz‐Buschart,et al. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder , 2017, Movement disorders : official journal of the Movement Disorder Society.
[9] Hongzhe Li,et al. A Logistic Normal Multinomial Regression Model for Microbiome Compositional Data Analysis , 2013, Biometrics.
[10] I. Saltykova,et al. Analysis of Gut Microbiota in Patients with Parkinson’s Disease , 2017, Bulletin of Experimental Biology and Medicine.
[11] G. Deuschl,et al. Gut microbiota in Parkinson disease in a northern German cohort , 2017, Brain Research.
[12] J Paul Brooks,et al. Challenges for case-control studies with microbiome data. , 2016, Annals of epidemiology.
[13] Jens Roat Kultima,et al. Potential of fecal microbiota for early‐stage detection of colorectal cancer , 2014 .